Delek US (NYSE:DK) Price Target Raised to $54.00 at Mizuho

Delek US (NYSE:DK) had its target price hoisted by Mizuho from $51.00 to $54.00 in a research note published on Tuesday morning,Benzinga reports. They currently have an outperform rating on the oil and gas company’s stock.

Other analysts have also issued reports about the company. JPMorgan Chase & Co. reduced their target price on Delek US from $42.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, January 15th. Morgan Stanley dropped their price target on Delek US from $40.00 to $38.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 27th. Scotiabank set a $34.00 price objective on shares of Delek US in a research report on Friday, January 16th. Weiss Ratings reissued a “sell (d-)” rating on shares of Delek US in a report on Wednesday, January 21st. Finally, TD Cowen boosted their target price on shares of Delek US from $28.00 to $44.00 and gave the company a “hold” rating in a research report on Thursday, March 5th. Four investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Delek US currently has a consensus rating of “Hold” and an average target price of $39.69.

Delek US Stock Up 2.9%

Shares of DK opened at $42.34 on Tuesday. The company has a current ratio of 0.82, a quick ratio of 0.53 and a debt-to-equity ratio of 5.89. Delek US has a 12 month low of $11.02 and a 12 month high of $45.74. The firm’s 50 day moving average is $34.00 and its 200-day moving average is $34.21. The stock has a market capitalization of $2.53 billion, a PE ratio of -120.97 and a beta of 0.75.

Delek US (NYSE:DK) last issued its quarterly earnings results on Friday, February 27th. The oil and gas company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.63. Delek US had a negative return on equity of 13.55% and a negative net margin of 0.21%.The business had revenue of $2.43 billion for the quarter, compared to the consensus estimate of $2.55 billion. During the same quarter in the prior year, the business posted ($2.54) earnings per share. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. Equities research analysts forecast that Delek US will post -5.5 EPS for the current year.

Delek US Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, March 2nd were given a $0.255 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $1.02 annualized dividend and a dividend yield of 2.4%. Delek US’s dividend payout ratio (DPR) is -291.43%.

Insider Buying and Selling

In other news, Director William J. Finnerty sold 5,392 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $42.75, for a total transaction of $230,508.00. Following the transaction, the director owned 46,369 shares in the company, valued at approximately $1,982,274.75. This represents a 10.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Shlomo Zohar sold 5,000 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $41.47, for a total value of $207,350.00. Following the completion of the sale, the director directly owned 13,989 shares of the company’s stock, valued at approximately $580,123.83. This trade represents a 26.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 159,752 shares of company stock worth $6,692,131 over the last ninety days. 3.56% of the stock is owned by company insiders.

Hedge Funds Weigh In On Delek US

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DK. Brown Brothers Harriman & Co. bought a new stake in shares of Delek US during the third quarter valued at about $27,000. Caitong International Asset Management Co. Ltd raised its position in Delek US by 95.6% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock valued at $26,000 after purchasing an additional 432 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Delek US by 173.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 968 shares of the oil and gas company’s stock worth $29,000 after buying an additional 614 shares during the last quarter. Torren Management LLC bought a new stake in shares of Delek US in the 4th quarter worth approximately $40,000. Finally, Focus Partners Wealth purchased a new stake in Delek US during the third quarter valued at about $44,000. Institutional investors own 97.01% of the company’s stock.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.